Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Bourrier A, Carrat F, Colombel JF, Bouvier AM, Abitbol V, Marteau P, Cosnes J, Simon T, Peyrin-Biroulet L, Beaugerie L; CESAME study group.

Aliment Pharmacol Ther. 2016 Jan;43(2):252-61. doi: 10.1111/apt.13466. Epub 2015 Nov 9.

PMID:
26549003
2.

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L; CESAME Study Group.

Gut. 2014 Sep;63(9):1416-23. doi: 10.1136/gutjnl-2013-305763. Epub 2013 Oct 25.

PMID:
24162591
3.

Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.

Gonzalvez F, D'Aurelio M, Boutant M, Moustapha A, Puech JP, Landes T, Arnauné-Pelloquin L, Vial G, Taleux N, Slomianny C, Wanders RJ, Houtkooper RH, Bellenguer P, Møller IM, Gottlieb E, Vaz FM, Manfredi G, Petit PX.

Biochim Biophys Acta. 2013 Aug;1832(8):1194-206. doi: 10.1016/j.bbadis.2013.03.005. Epub 2013 Mar 20.

4.

Characterization of seven novel mutations on the HEXB gene in French Sandhoff patients.

Gaignard P, Fagart J, Niemir N, Puech JP, Azouguene E, Dussau J, Caillaud C.

Gene. 2013 Jan 10;512(2):521-6. doi: 10.1016/j.gene.2012.09.124. Epub 2012 Oct 6.

PMID:
23046579
5.

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.

Sokol H, Beaugerie L, Maynadié M, Laharie D, Dupas JL, Flourié B, Lerebours E, Peyrin-Biroulet L, Allez M, Simon T, Carrat F, Brousse N; CESAME Study Group.

Inflamm Bowel Dis. 2012 Nov;18(11):2063-71. doi: 10.1002/ibd.22889. Epub 2012 Jan 23.

PMID:
22271569
6.

Use of parenteral lipid emulsions in French neonatal ICUs.

Lapillonne A, Fellous L, Kermorvant-Duchemin E; French neonatal departments.

Nutr Clin Pract. 2011 Dec;26(6):672-80. doi: 10.1177/0884533611425681.

PMID:
22205555
7.

[Health care workers' knowledge and vaccination coverage against pertussis in a French pediatric and maternity ward].

Vic P, Puech J.

Arch Pediatr. 2011 Dec;18(12):1339-40. doi: 10.1016/j.arcped.2011.09.029. Epub 2011 Oct 30. French. No abstract available.

PMID:
22041593
8.

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.

Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L; Cesame Study Group.

Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050. Epub 2011 Jun 25.

PMID:
21708105
9.

[A rare cause of cardiogenic shock treated by extracorporeal life support: catecholamine secreting paraganglioma].

Xeridat F, Vidal V, Puech JB, Gariboldi V, Kerbaul F.

Ann Fr Anesth Reanim. 2011 Apr;30(4):363-5. doi: 10.1016/j.annfar.2011.01.018. Epub 2011 Mar 15. French.

PMID:
21411267
10.

A canine Arylsulfatase G (ARSG) mutation leading to a sulfatase deficiency is associated with neuronal ceroid lipofuscinosis.

Abitbol M, Thibaud JL, Olby NJ, Hitte C, Puech JP, Maurer M, Pilot-Storck F, Hédan B, Dréano S, Brahimi S, Delattre D, André C, Gray F, Delisle F, Caillaud C, Bernex F, Panthier JJ, Aubin-Houzelstein G, Blot S, Tiret L.

Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14775-80. doi: 10.1073/pnas.0914206107. Epub 2010 Aug 2.

11.

Rapid identification of HEXA mutations in Tay-Sachs patients.

Giraud C, Dussau J, Azouguene E, Feillet F, Puech JP, Caillaud C.

Biochem Biophys Res Commun. 2010 Feb 19;392(4):599-602. doi: 10.1016/j.bbrc.2010.01.088. Epub 2010 Jan 25.

PMID:
20100466
12.

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group.

Lancet. 2009 Nov 7;374(9701):1617-25. doi: 10.1016/S0140-6736(09)61302-7.

PMID:
19837455
13.
14.

Prevention of neuropathology in the mouse model of Hurler syndrome.

Desmaris N, Verot L, Puech JP, Caillaud C, Vanier MT, Heard JM.

Ann Neurol. 2004 Jul;56(1):68-76.

PMID:
15236403
15.

Muscle as a putative producer of acid alpha-glucosidase for glycogenosis type II gene therapy.

Martin-Touaux E, Puech JP, Château D, Emiliani C, Kremer EJ, Raben N, Tancini B, Orlacchio A, Kahn A, Poenaru L.

Hum Mol Genet. 2002 Jul 1;11(14):1637-45.

17.

Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation.

Laforêt P, Nicolino M, Eymard PB, Puech JP, Caillaud C, Poenaru L, Fardeau M.

Neurology. 2000 Oct 24;55(8):1122-8.

PMID:
11071489
18.

Identification of a precursor of beta-methyl-gamma-octalactone in the wood of sessile oak (Quercus petraea (Matt.) Liebl.).

Masson E, Baumes R, Le Guernevé C, Puech JL.

J Agric Food Chem. 2000 Sep;48(9):4306-9.

PMID:
10995355
19.

Evolution of castalagin and vescalagin in ethanol solutions. Identification of new derivatives.

Puech JL, Mertz C, Michon V, Le Guernevé C, Doco T, Hervé Du Penhoat C.

J Agric Food Chem. 1999 May;47(5):2060-6.

PMID:
10552496
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk